NM_001369.3:c.7609+19C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001369.3(DNAH5):c.7609+19C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.387 in 1,549,262 control chromosomes in the GnomAD database, including 117,563 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.38 ( 11042 hom., cov: 32)
Exomes 𝑓: 0.39 ( 106521 hom. )
Consequence
DNAH5
NM_001369.3 intron
NM_001369.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0950
Publications
5 publications found
Genes affected
DNAH5 (HGNC:2950): (dynein axonemal heavy chain 5) This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009]
DNAH5 Gene-Disease associations (from GenCC):
- primary ciliary dyskinesia 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, ClinGen
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 5-13810040-G-A is Benign according to our data. Variant chr5-13810040-G-A is described in ClinVar as Benign. ClinVar VariationId is 197516.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.607 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DNAH5 | ENST00000265104.5 | c.7609+19C>T | intron_variant | Intron 45 of 78 | 1 | NM_001369.3 | ENSP00000265104.4 | |||
| DNAH5 | ENST00000681290.1 | c.7564+19C>T | intron_variant | Intron 45 of 78 | ENSP00000505288.1 | |||||
| DNAH5 | ENST00000512443.1 | n.465+19C>T | intron_variant | Intron 1 of 2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.377 AC: 57223AN: 151922Hom.: 11038 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
57223
AN:
151922
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.393 AC: 60520AN: 154048 AF XY: 0.390 show subpopulations
GnomAD2 exomes
AF:
AC:
60520
AN:
154048
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.388 AC: 542739AN: 1397226Hom.: 106521 Cov.: 35 AF XY: 0.387 AC XY: 266642AN XY: 689292 show subpopulations
GnomAD4 exome
AF:
AC:
542739
AN:
1397226
Hom.:
Cov.:
35
AF XY:
AC XY:
266642
AN XY:
689292
show subpopulations
African (AFR)
AF:
AC:
10313
AN:
31578
American (AMR)
AF:
AC:
14558
AN:
35844
Ashkenazi Jewish (ASJ)
AF:
AC:
9041
AN:
25154
East Asian (EAS)
AF:
AC:
20544
AN:
35856
South Asian (SAS)
AF:
AC:
27066
AN:
79204
European-Finnish (FIN)
AF:
AC:
17781
AN:
49160
Middle Eastern (MID)
AF:
AC:
1481
AN:
4068
European-Non Finnish (NFE)
AF:
AC:
419427
AN:
1078568
Other (OTH)
AF:
AC:
22528
AN:
57794
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
16852
33705
50557
67410
84262
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
13296
26592
39888
53184
66480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.377 AC: 57252AN: 152036Hom.: 11042 Cov.: 32 AF XY: 0.376 AC XY: 27921AN XY: 74302 show subpopulations
GnomAD4 genome
AF:
AC:
57252
AN:
152036
Hom.:
Cov.:
32
AF XY:
AC XY:
27921
AN XY:
74302
show subpopulations
African (AFR)
AF:
AC:
13490
AN:
41478
American (AMR)
AF:
AC:
6101
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
1272
AN:
3470
East Asian (EAS)
AF:
AC:
3224
AN:
5162
South Asian (SAS)
AF:
AC:
1659
AN:
4812
European-Finnish (FIN)
AF:
AC:
3729
AN:
10576
Middle Eastern (MID)
AF:
AC:
109
AN:
294
European-Non Finnish (NFE)
AF:
AC:
26371
AN:
67940
Other (OTH)
AF:
AC:
820
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1844
3688
5533
7377
9221
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
566
1132
1698
2264
2830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1562
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Mar 16, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Primary ciliary dyskinesia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Primary ciliary dyskinesia 3 Benign:1
Jun 15, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.